Dr Reddy's Laboratories - Stock Price History | RDY

Historical daily share price chart and data for Dr Reddy's Laboratories since 2019 adjusted for splits. The latest closing stock price for Dr Reddy's Laboratories as of December 10, 2019 is 41.08.
  • The all-time high Dr Reddy's Laboratories stock closing price was 67.79 on October 19, 2015.
  • The Dr Reddy's Laboratories 52-week high stock price is 42.82, which is 4.2% above the current share price.
  • The Dr Reddy's Laboratories 52-week low stock price is 34.67, which is 15.6% below the current share price.
  • The average Dr Reddy's Laboratories stock price for the last 52 weeks is 38.30.
Dr Reddy's Laboratories Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 33.7714 38.0900 39.5400 28.4900 37.7000 0.37%
2017 38.9331 45.4400 46.7000 30.1100 37.5600 -17.05%
2016 46.2125 45.6500 54.4500 41.2200 45.2800 -2.18%
2015 56.3194 50.1100 67.7900 43.5500 46.2900 -8.25%
2014 46.3439 40.3000 58.3900 38.6700 50.4500 22.96%
2013 36.7077 34.1900 41.1900 32.0000 41.0300 23.25%
2012 31.7270 30.1500 35.0600 27.4100 33.2900 13.12%
2011 33.8428 37.3300 39.2400 29.0700 29.4300 -20.37%
2010 30.7362 24.8800 41.7600 23.3400 36.9600 52.66%
2009 15.3837 10.2100 26.1300 7.4100 24.2100 147.04%
2008 13.2925 18.2800 18.2800 7.5300 9.8000 -46.04%
2007 16.3241 18.1000 18.5800 14.5100 18.1600 -0.22%
2006 15.2735 10.9000 19.0600 10.9000 18.2000 68.52%
2005 9.0628 9.8600 10.9250 7.5600 10.8000 8.93%
2004 10.2201 16.1000 16.5050 7.5400 9.9150 -37.35%
2003 11.4112 9.8300 16.0700 8.8500 15.8250 63.74%
2002 9.5612 9.6000 11.9000 6.8800 9.6650 2.01%
2001 9.4095 5.0500 12.7000 5.0500 9.4750 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $6.698B $2.225B
Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally, with focus on India, US, Europe and Russia. They conduct research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $61.181B 11.15
Teva Pharmaceutical Industries (TEVA) Israel $10.834B 4.41
Bausch Health Cos (BHC) Canada $10.259B 6.77
Mylan (MYL) United States $9.956B 4.47
ASPEN PHARMACR (APNHY) South Africa $3.391B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.198B 11.59
Amphastar Pharmaceuticals (AMPH) United States $0.888B 46.15
Homology Medicines (FIXX) United States $0.800B 0.00
Voyager Therapeutics (VYGR) United States $0.518B 0.00
Akorn (AKRX) United States $0.473B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.442B 0.00
Assembly Biosciences (ASMB) United States $0.428B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.287B 0.39
Adamas Pharmaceuticals (ADMS) United States $0.180B 0.00
Sol-Gel Technologies (SLGL) Israel $0.158B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.131B 0.00
CymaBay Therapeutics (CBAY) United States $0.120B 0.00
Teligent (TLGT) United States $0.033B 0.00
China Pharma Holdings (CPHI) China $0.011B 0.00